We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Healthcare 10.8%
3 Consumer Discretionary 9.19%
4 Financials 8.28%
5 Communication Services 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIRX
5276
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$4K ﹤0.01%
908
-965
-52% -$2.75K
BRKHU
5277
DELISTED
BurTech Acquisition Corp. Unit
BRKHU
$4K ﹤0.01%
386
-3
-0.8% -$30
NVEI
5278
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
$4K ﹤0.01%
97
-2,010
-95% -$105K
LILM
5279
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
$4K ﹤0.01%
1,664
+1,455
+696% +$4.57K
VSACU
5280
DELISTED
Vision Sensing Acquisition Corp. Unit
VSACU
$4K ﹤0.01%
359
CALT
5281
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
$4K ﹤0.01%
245
-138
-36% -$2.4K
KA
5282
DELISTED
Kineta, Inc. Common Stock
KA
$4K ﹤0.01%
350
-293
-46% -$2.81K
AACIU
5283
DELISTED
Armada Acquisition Corp. I Unit
AACIU
$4K ﹤0.01%
419
IMAQ
5284
DELISTED
International Media Acquisition Corp. Class A Common Stock
IMAQ
$4K ﹤0.01%
426
+205
+93% +$2.04K
TPHS
5285
DELISTED
Trinity Place Holdings Inc.com
TPHS
$4K ﹤0.01%
4,069
+734
+22% +$961
GPACU
5286
DELISTED
Global Partner Acquisition Corp II Unit
GPACU
$4K ﹤0.01%
368
-3
-0.8% -$30
CSSE
5287
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
$4K ﹤0.01%
572
-1,129
-66% -$8.65K
ENG
5288
DELISTED
ENGlobal Corp
ENG
$4K ﹤0.01%
463
-89
-16% -$811
MVLA
5289
DELISTED
Movella Holdings Inc. Common Stock
MVLA
$4K ﹤0.01%
420
-315
-43% -$3.09K
VRPX
5290
DELISTED
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
$4K ﹤0.01%
+10
New +$4.1K
BPTH
5291
DELISTED
Bio-Path Holdings Inc
BPTH
$4K ﹤0.01%
57
-4
-7% -$270
OPA
5292
DELISTED
Magnum Opus Acquisition Limited
OPA
$4K ﹤0.01%
370
+60
+19% +$591
ORTX
5293
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$4K ﹤0.01%
722
-970
-57% -$5.47K
LVOX
5294
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
$4K ﹤0.01%
+2,678
New +$6.6K
NETC
5295
DELISTED
Nabors Energy Transition Corp.
NETC
$4K ﹤0.01%
430
-35
-8% -$350
CWBR
5296
DELISTED
CohBar, Inc. Common Stock
CWBR
$4K ﹤0.01%
650
+317
+95% +$2.12K
SCU
5297
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$4K ﹤0.01%
454
-5,604
-93% -$61.8K
ITAQU
5298
DELISTED
Industrial Tech Acquisitions II, Inc. Unit
ITAQU
$4K ﹤0.01%
399
BOAC
5299
DELISTED
Bluescape Opportunities Acquisition Corp.
BOAC
$4K ﹤0.01%
411
-283
-41% -$2.8K
BTWN
5300
DELISTED
Bridgetown Holdings Limited Class A Ordinary Shares
BTWN
$4K ﹤0.01%
385
-481
-56% -$4.76K

Similar funds

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.